CRISPR Technology Market by Product (Enzymes, Kits & Reagents, Guide RNA, Others), Application (Biomedical Applications, Agricultural Applications, Industrial Applications, Biological Research), End-User (Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations) and by Region Global Trends and Forecast from 2022 to 2029

Published on: Oct 2023
From:USD $3499.00
Number Of Pages:79

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 9.76 billion by 2029	25.3 %	North America

by Product	by Application	by End-User
Enzymes Kits & Reagents Guide RNA Others	Biomedical Applications Agricultural Applications Industrial Applications Biological Research	Pharmaceutical and Biopharmaceutical Companies Biotechnology Companies Academic and Research Institutes Contract Research Organization

5/5 - (17 votes)

CRISPR Technology Market Overview

The global CRISPR technology market is projected to reach USD 9.76 billion by 2029 from USD 1.46 billion in 2020, at a CAGR of 25.3 % from 2022 to 2029.

CRISPR has been defined as a genome editing technique. It is a kind of DNA sequence found in prokaryotic cells such as microbes. CRISPR technology is used to detect and delete DNA from microbes during contamination. This technique enables the addition, removal, or modification of genetic material at specific sites in the genome. These specific configurations play an important role in the anti-phage protective system of prokaryotes. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) technology has established the restoration system, which is regarded as one of the greatest approaches for genome editing.

CRISPR Technology Market | Exactitude Consultancy

The CRISPR technology works by using a molecule called Cas9, which acts as a pair of molecular scissors that can cut DNA at a specific location. Researchers can program Cas9 to target a specific gene or sequence of DNA, and then introduce it into cells. Once inside the cells, Cas9 cuts the DNA at the target site, which triggers a natural repair process that can be harnessed to make precise edits to the genome.

CRISPR technology has the potential to revolutionize healthcare by providing new treatments for genetic diseases, such as cystic fibrosis and sickle cell anemia. It can also be used to develop personalized medicine and to improve the accuracy and efficiency of drug discovery. The technology is also being used in agriculture to develop crops that are more resistant to pests and diseases, and in biotechnology to produce new materials and chemicals.

It is used to change the DNA sequence and modify gene function. Its primary applications include repairing genetic abnormalities, curing and reducing disease transmission, and enhancing crops. The primary reasons linked to the growth of the CRISPR industry are technical improvements. Increased genetic prevalence and expanding medication discovery efforts are likely to drive market revenue growth. The rising demand for synthetic genes, as well as a rise in biotechnology R&D spending and government funding for genetic research, are fueling the expansion of the CRISPR industry.

The ethical and regulatory considerations around the application of CRISPR technology in humans are major limitations. The ability to edit genes with precision raises questions about the safety and efficacy of the technology, as well as the ethical implications of editing the human genome. As a result, there are strict regulations and guidelines in place that limit the use of CRISPR technology in human trials. However, problems such as gene editing of germ line cells are hindering the growth of the market. Since the alterations made in germ line cells are transferred to the next generations. The gene editing of germ line cells also has ethical issues and is unlawful in most of the countries. Limited awareness is another factor hindering the growth of the CRISPR market.

The potential for technology to change healthcare is one of the biggest opportunities. CRISPR technology has the potential to cure genetic diseases and develop new therapies, which could revolutionize the way we approach healthcare. The technology is also being used to develop new diagnostic tools, which could help detect diseases at an earlier stage, improving patient outcomes and reducing healthcare costs. The potential for CRISPR technology to change agriculture is another possibility in the CRISPR technology industry. The technology can be used to develop crops that are more resistant to pests and diseases, increasing yields and reducing the need for harmful pesticides.

ATTRIBUTE	DETAILS
Study period	2022-2029
Base year	2022
Estimated year	2023
Forecasted year	2023-2029
Historical period	2018-2022
Unit	Value (USD Billion)
Segmentation	By Product, By Application, By End-User, By Region
By Product	Enzymes Kits & Reagents Guide RNA Others
By Application	Biomedical Applications Agricultural Applications Industrial Applications Biological Research
By End-User	Pharmaceutical and Biopharmaceutical Companies Biotechnology Companies Academic and Research Institutes Contract Research Organizations
By Region	North America Europe Asia Pacific South America MEA

CRISPR Technology Market Segment Analysis

The global CRISPR technology market is segmented by product, application, and region.

Based on product, the CRISPR technology market is segmented into enzymes, kits & reagents, guide RNA, others. Enzymes are a crucial component of the CRISPR technology system, as they are responsible for cutting and editing DNA. Cas9, the most widely used enzyme in the CRISPR system, is highly specific and can be customized to target specific DNA sequences. As a result, enzymes are a popular product category in the CRISPR technology market. Kits & reagents are another important product category in the CRISPR technology market. These kits and reagents are designed to simplify and streamline the CRISPR technology process, making it easier for researchers to use the technology in their experiments.

Guide RNA is another critical component of the CRISPR system, as it is responsible for guiding the Cas9 enzyme to the specific DNA sequence that needs to be edited. Guide RNA products can be designed to target specific genes, making them highly specific and effective tools for gene editing.

Based on application, the CRISPR technology market is classified into biomedical applications, agricultural applications, industrial applications, biological research. The biomedical application segment is expected to dominate the CRISPR technology market in the coming years. Biomedical applications of CRISPR technology involve the use of gene editing to treat genetic disorders and diseases. The technology offers a highly targeted and precise way to modify genes, making it a promising tool for developing new treatments and therapies.

Agricultural applications of CRISPR technology involve the use of gene editing to improve crop yields, resistance to pests and disease, and other desirable traits. This application is particularly relevant for meeting the growing demand for food production, especially as climate change and other environmental factors continue to impact agricultural productivity.

Based on end-users, the CRISPR technology market is bifurcated into pharmaceutical and biopharmaceutical companies, biotechnology companies, academic and research institutes, contract research organizations. Pharmaceutical and biopharmaceutical companies are expected to be the dominant end-users in the CRISPR technology market. These companies are heavily investing in CRISPR technology to develop new and more effective treatments for diseases and genetic disorders.

Biotechnology companies are another significant end-user of CRISPR technology. These companies are leveraging CRISPR technology to develop innovative therapies and solutions for various diseases and disorders.

CRISPR Technology Market Players

The global CRISPR technology market key players include CRISPR Therapeutics, Intellia Therapeutics, Editas Medicine, Mammoth Biosciences, Caribou Biosciences, Synthego, Horizon Discovery, Thermo Fisher Scientific, Genscript Biotech, Origene Technologies, Merck, Addgene

Recent News:

April 3, 2023 – CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced the completion of the rolling Biologics License Applications (BLAs) to the U.S. Food and Drug Administration (FDA) for the investigational treatment exagamglogene autotemcel (exa-cel) for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).
March 2, 2023: Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for NTLA-2002 for the treatment of hereditary angioedema (HAE), enabling the company to include the United States in the global Phase 2 portion of its ongoing Phase 1/2 study.

Who Should Buy? Or Key stakeholders

Pharmaceutical and biopharmaceutical companies
Biotechnology companies
Academic and research institutes
Contract research organizations (CROs)
Government and regulatory agencies
Healthcare providers and hospitals
Investors and venture capitalists
Genetic testing and diagnostic laboratories
Genome editing service providers.

CRISPR Technology Market Regional Analysis

The CRISPR technology market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America emerged as the leading market for CRISPR technology in 2021, with a market share of around 35%. The CRISPR market in North America is expected to grow significantly during the forecast period due to the numerous benefits associated with the use of CRISPR technology, as well as numerous technological innovations, product approvals, and government policies. The United States is a key contributor to the growth of the CRISPR technology market in North America, with a big number of pharmaceutical and biotechnology companies actively investing in the technology. Furthermore, favorable regulatory rules in the United States have aided in the acceleration of the CRISPR technology market.

The Asia-Pacific region is expected to witness significant growth in the CRISPR technology market due to increasing investments in healthcare and life sciences, rising demand for precision medicine, and a growing focus on developing innovative therapies for various diseases and disorders. China, Japan, and India are expected to be the key players in the Asia-Pacific CRISPR technology market.

Key Market Segments: CRISPR Technology Market

CRISPR Technology Market by Product 2022-2029, (USD Billion)

Enzymes
Kits & Reagents
Guide RNA
Others

CRISPR Technology Market by Application, 2022-2029, (USD Billion)

Biomedical Applications
Agricultural Applications
Industrial Applications
Biological Research

CRISPR Technology Market by End-User, 2022-2029, (USD Billion)

Pharmaceutical and Biopharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organization

CRISPR Technology Market by Regions, 2022-2029, (USD Billion)

North America
Europe
Asia Pacific
South America
Middle East and Africa

Important Countries in All Regions Are Covered

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new technology
Improving profitability
Entering new markets
Enhancing brand reputation

Key Question Answered

What is the expected growth rate of the CRISPR technology market over the next 7 years?
Who are the major players in the CRISPR technology market and what is their market share?
What are the end-user industries driving demand for market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
How is the economic environment affecting the CRISPR technology market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the CRISPR technology market?
What is the current and forecasted size and growth rate of the global CRISPR technology market?
What are the key drivers of growth in the CRISPR technology market?
What are the distribution channels and supply chain dynamics in the CRISPR technology market?
What are the technological advancements and innovations in the CRISPR technology market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the CRISPR technology market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the CRISPR technology market?
What are the service offerings and specifications of leading players in the market?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL CRISPR TECHNOLOGY MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON CRISPR TECHNOLOGY MARKET
3. PORTER’S FIVE FORCES MODEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL CRISPR TECHNOLOGY MARKET BY PRODUCT, 2020-2029, (USD BILLION)
1. ENZYMES
2. KITS & REAGENTS
3. GUIDE RNA
4. OTHERS
GLOBAL CRISPR TECHNOLOGY MARKET BY APPLICATION, 2020-2029, (USD BILLION)
1. BIOMEDICAL APPLICATIONS
2. AGRICULTURAL APPLICATIONS
3. INDUSTRIAL APPLICATIONS
4. BIOLOGICAL RESEARCH
GLOBAL CRISPR TECHNOLOGY MARKET BY END-USER, 2020-2029, (USD BILLION)
1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
2. BIOTECHNOLOGY COMPANIES
3. ACADEMIC AND RESEARCH INSTITUTES
4. CONTRACT RESEARCH ORGANIZATIONS
GLOBAL CRISPR TECHNOLOGY MARKET BY REGION, 2020-2029, (USD BILLION)
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCT OFFERED, RECENT DEVELOPMENTS)

CRISPR THERAPEUTICS
EDITAS MEDICINE
MAMMOTH BIOSCIENCES
CARIBOU BIOSCIENCES
SYNTHEGO
HORIZON DISCOVERY
THERMO FISHER SCIENTIFIC
GENSCRIPT BIOTECH
ORIGENE TECHNOLOGIES
TITAN OIL RECOVERY
MERCK
ADDGENE *THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 2 GLOBAL CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 3 GLOBAL CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 4 GLOBAL CRISPR TECHNOLOGY MARKET BY REGION (USD BILLION) 2020-2029

TABLE 5 NORTH AMERICA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 6 NORTH AMERICA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 7 NORTH AMERICA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 8 NORTH AMERICA CRISPR TECHNOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 9 US CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 10 US CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 11 US CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 12 CANADA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 13 CANADA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 14 CANADA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 15 MEXICO CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 16 MEXICO CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 17 MEXICO CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 18 SOUTH AMERICA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 19 SOUTH AMERICA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 20 SOUTH AMERICA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 21 SOUTH AMERICA CRISPR TECHNOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 22 BRAZIL CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 23 BRAZIL CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 24 BRAZIL CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 25 ARGENTINA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 26 ARGENTINA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 27 ARGENTINA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 28 COLOMBIA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 29 COLOMBIA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 30 COLOMBIA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 31 REST OF SOUTH AMERICA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 32 REST OF SOUTH AMERICA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 33 REST OF SOUTH AMERICA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 34 ASIA-PACIFIC CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 35 ASIA-PACIFIC CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 36 ASIA-PACIFIC CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 37 ASIA-PACIFIC CRISPR TECHNOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 38 INDIA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 39 INDIA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 40 INDIA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 41 CHINA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 42 CHINA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 43 CHINA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 44 JAPAN CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 45 JAPAN CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 46 JAPAN CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 47 SOUTH KOREA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 48 SOUTH KOREA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 49 SOUTH KOREA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 50 AUSTRALIA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 51 AUSTRALIA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 52 AUSTRALIA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 53 SOUTH-EAST ASIA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 54 SOUTH-EAST ASIA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 55 SOUTH-EAST ASIA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 56 REST OF ASIA PACIFIC CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 57 REST OF ASIA PACIFIC CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 58 REST OF ASIA PACIFIC CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 59 EUROPE CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 60 EUROPE CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 61 EUROPE CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 62 EUROPE CRISPR TECHNOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 63 GERMANY CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 64 GERMANY CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 65 GERMANY CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 66 UK CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 67 UK CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 68 UK CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 69 FRANCE CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 70 FRANCE CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 71 FRANCE CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 72 ITALY CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 73 ITALY CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 74 ITALY CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 75 SPAIN CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 76 SPAIN CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 77 SPAIN CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 78 RUSSIA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 79 RUSSIA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 80 RUSSIA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 81 REST OF EUROPE CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 82 REST OF EUROPE CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 83 REST OF EUROPE CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 84 MIDDLE EAST AND AFRICA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 85 MIDDLE EAST AND AFRICA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 86 MIDDLE EAST AND AFRICA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 87 MIDDLE EAST AND AFRICA CRISPR TECHNOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 88 UAE CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 89 UAE CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 90 UAE CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 91 SAUDI ARABIA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 92 SAUDI ARABIA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 93 SAUDI ARABIA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 94 SOUTH AFRICA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 95 SOUTH AFRICA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 96 SOUTH AFRICA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

TABLE 97 REST OF MIDDLE EAST AND AFRICA CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 98 REST OF MIDDLE EAST AND AFRICA CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 99 REST OF MIDDLE EAST AND AFRICA CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2020-2029

FIGURE 9 GLOBAL CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029

FIGURE 10 GLOBAL CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2020-2029

FIGURE 11 GLOBAL CRISPR TECHNOLOGY MARKET BY REGION (USD BILLION) 2020-2029

FIGURE 12 PORTER’S FIVE FORCES MODEL

FIGURE 13 GLOBAL CRISPR TECHNOLOGY MARKET BY PRODUCT (USD BILLION) 2021

FIGURE 14 GLOBAL CRISPR TECHNOLOGY MARKET BY APPLICATION (USD BILLION) 2021

FIGURE 15 GLOBAL CRISPR TECHNOLOGY MARKET BY END-USER (USD BILLION) 2021

FIGURE 16 GLOBAL CRISPR TECHNOLOGY MARKET BY REGION (USD BILLION) 2021

FIGURE 17 MARKET SHARE ANALYSIS

FIGURE 18 CRISPR THERAPEUTICS: COMPANY SNAPSHOT

FIGURE 19 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT

FIGURE 20 EDITAS MEDICINE: COMPANY SNAPSHOT

FIGURE 21 MAMMOTH BIOSCIENCES: COMPANY SNAPSHOT

FIGURE 22 CARIBOU BIOSCIENCES: COMPANY SNAPSHOT

FIGURE 23 SYNTHEGO: COMPANY SNAPSHOT

FIGURE 24 HORIZON DISCOVERY: COMPANY SNAPSHOT

FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 26 GENSCRIPT BIOTECH: COMPANY SNAPSHOT

FIGURE 27 ORIGENE TECHNOLOGIES: COMPANY SNAPSHOT

FIGURE 28 MERCK: COMPANY SNAPSHOT

FIGURE 29 ADDGENE: COMPANY SNAPSHOT

• What is the worth of the CRISPR technology market?

The global CRISPR technology market is projected to reach USD 9.76 billion by 2029 from USD 1.46 billion in 2020, at a CAGR of 25.3 % from 2022 to 2029.

• What is the share of the North America CRISPR technology industry?

• Which are the top companies to hold the market share in the CRISPR technology market?

• What is the CAGR of CRISPR technology market?

The global CRISPR technology market registered a CAGR of 25.3 % from 2022 to 2029.

• What are the factors driving the CRISPR Technology Market?

Factors such as the increasing availability of government and private financing, as well as the increasing use of CRISPR across end users, are driving the market’s growth.

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT